IBM, Pfizer launch joint experiment to help measure Parkinson’s symptoms using IoT and analytics

 What happens when you put a technology company together with a drug company and try to come up with unique new ways to understand Parkinson’s disease? You end up with a project that uses sensors on the body and in the home to provide continuous measurement of a patient’s symptoms and the impact they have on that person’s daily life, something that’s almost impossible to… Read More
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.